商品名：Maxipime
Antibacterial drug of the cephalosporin class. Action against bacterial cell walls is similar to other cephalosporins. Cefepime is one of the fourth-generation cephalosporins. It has an enhanced, extended spectrum that is beyond that of the older cephalosporins. Its activity includes gram-positive cocci and gram-negative bacilli. It has been active against organisms resistant to other beta-lactams such as Escherichia coli and Klebsiella. It is active against most Pseudomonas aeruginosa. It is not active against methicillin-resistant staphylococci, Bacteroides fragilis, or penicillin-resistant enterococci.
Cefepime is a fourth-generation cephalosporin. Although it has a broader spectrum than other cephalosporins, the use has been limited in veterinary medicine. Experimental studies have been conducted in foals, adult horses, and dogs to establish doses, but reports of efficacy are not available.
劑量數字暫停提供：VetPro 的劑量改依 DRUGAPI 藥物資料庫對外的內容，DRUGAPI 目前不提供可直接計算的劑量。下方列出 DRUGAPI 的審查結論與劑量審查引用的來源；計算機可手動輸入劑量換算。
腎功能調整：Extend interval to q12-24h in renal failure
腎功能調整：Extend interval to q12-24h in renal failure
腎功能調整：Extend interval to q12-24h in renal failure
犬與成馬只有小型健康動物 PK 推估，馬駒資料限敗血重症脈絡；現況卻把犬 IV 推估加上未支持 IM／CRI／固定腎間隔，並把貓列可用。具名產品、route、病原／MIC、感染部位、腎功能、水合、神經、物種／life stage 與專科監督 gate 前封鎖計算、處方與飼主劑量。
依出現頻率分組；嚴重副作用獨立列出，臨床上需立即辨識。
1.1 hours